The CDC has been actively investigating the long-term effects of myocarditis linked to mRNA Covid-19

 

The CDC has been actively investigating the long-term effects of myocarditis, especially after reports of cases linked to mRNA COVID-19 vaccines, such as those from Pfizer-BioNTech and Moderna. Myocarditis, an inflammation of the heart muscle, has been primarily reported in younger males, particularly after the second dose of the vaccine. While most cases have been mild, with patients recovering quickly after treatment, the CDC has emphasized the importance of monitoring these cases for potential long-term health impacts.

Ongoing efforts include contacting individuals (or their guardians) who meet the case definition for myocarditis, gathering data on their recovery, and collaborating with healthcare providers to ensure comprehensive follow-ups. Initial surveys have shown that nearly 80% of individuals diagnosed with myocarditis have either fully recovered or are expected to recover fully under medical care.

Despite these reports, the CDC maintains that the benefits of COVID-19 vaccination, which include preventing severe illness, hospitalization, and death, outweigh the risks of myocarditis. This is particularly relevant for young adults and adolescents, where vaccination also helps reduce community transmission and protect against new variants​

CDC Stacks

​

CDC Stacks

​

CDC

.

For those interested, further details can be found on the CDC's official site.